StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences rebates & chargebacks rollforward — Total payments ($M) ($M)

Form 10-K Critical Accounting Estimates

Latest, FY2025
16,967
Period ended Dec 31, 2025
Change on a year earlier
+10.9%
15,305 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRebates & chargebacks rollforward — Total payments ($M) ($M)Year on yearSource
FY2025Dec 31, 202516,967+10.9%Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗
FY2024Dec 31, 202415,305+10.8%Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗
FY2023Dec 31, 202313,810+10.4%Form 10-K (gild-20241231.htm, filed 2025-02-28) ↗
FY2022Dec 31, 202212,509-1.4%Form 10-K (gild-20231231.htm, filed 2024-02-23) ↗
FY2021Dec 31, 202112,691-2.8%Form 10-K (gild-20221231.htm, filed 2023-02-22) ↗
FY2020Dec 31, 202013,060-5.5%Form 10-K (gild-20211231.htm, filed 2022-02-23) ↗
FY2019Dec 31, 201913,824-10.5%Form 10-K (gild-20201231.htm, filed 2021-02-25) ↗
FY2018Dec 31, 201815,449-4.4%Form 10-K (a2019form10-k.htm, filed 2020-02-25) ↗
FY2017Dec 31, 201716,158-12.4%Form 10-K (a2017form10-k.htm, filed 2018-02-27) ↗
FY2016Dec 31, 201618,439+32.5%Form 10-K (a2017form10-k.htm, filed 2018-02-27) ↗
FY2015Dec 31, 201513,918+200.3%Form 10-K (a2016form10-k.htm, filed 2017-02-27) ↗
FY2014Dec 31, 20144,635+53.1%Form 10-K (a2015form10-k.htm, filed 2016-02-24) ↗
FY2013Dec 31, 20133,028–Form 10-K (a2014form10-k.htm, filed 2015-02-25) ↗

Breakdown

What makes up rebates & chargebacks rollforward — total payments ($m)

Cite this data

StockData. (2026). Gilead Sciences Rebates & chargebacks rollforward — Total payments ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/reb_pay_tot

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.